GGrantIndex
← Leaderboards

Judith G. Rabkin

New York State Psychiatric Institute

$6,485,179
Attributed
$6,842,955
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $533.3K · FY200517
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$6,842,955 · 6

By mechanism

R01$6,127,402 · 5
R34$715,553 · 1

Top collaborators

Most similar at New York State Psychiatric Institute

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchMoodsAnti-Retroviral AgentsHuman SubjectFatigueDoseModafinilResponseMental DepressionClinically SignificantLifeAids/Hiv ProblemPharmaceutical PreparationsDepressionCommunitiesAdultInterestCounselingClinicBehavior TherapyMental HealthBehavioralBaseEmployment

Grant awards (20)

Return to Work RCT: Counseling after Fatigue Treatment in HIV/AIDS$398,032
R01 · FY2017 · MH · contact PI
Return to Work RCT: Counseling after Fatigue Treatment in HIV/AIDS$526,805
R01 · FY2016 · MH · contact PI
Return to Work RCT: Counseling after Fatigue Treatment in HIV/AIDS$525,993
R01 · FY2015 · MH · contact PI
Return to Work RCT: Counseling after Fatigue Treatment in HIV/AIDS$533,281
R01 · FY2014 · MH · contact PI
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS$79,151
R34 · FY2012 · MH · contact PI
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS$316,602
R34 · FY2011 · MH · contact PI
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS$319,800
R34 · FY2010 · MH · contact PI
Modafinil Treatment for Fatigue in HIV+ Patients$282,326
R01 · FY2008 · MH · contact PI
Modafinil Treatment for Fatigue in HIV+ Patients$354,880
R01 · FY2007 · MH · contact PI
Modafinil Treatment for Fatigue in HIV+ Patients$355,652
R01 · FY2006 · MH · contact PI
Modafinil Treatment for Fatigue in HIV+ Patients$318,606
R01 · FY2005 · MH
DYING AT HOME OF AIDS &CANCER: PREFERENCES &OUTCOMES$212,820
R01 · FY2004 · NR
DYING AT HOME OF AIDS &CANCER: PREFERENCES &OUTCOMES$427,916
R01 · FY2003 · NR
DHEA EFFECTS ON MOOD IN DEPRESSED HIV+ PATIENTS$377,403
R01 · FY2003 · MH
DHEA EFFECTS ON MOOD IN DEPRESSED HIV+ PATIENTS$417,449
R01 · FY2002 · MH
DYING AT HOME OF AIDS &CANCER: PREFERENCES &OUTCOMES$342,226
R01 · FY2002 · NR
DHEA EFFECTS ON MOOD IN DEPRESSED HIV+ PATIENTS$410,165
R01 · FY2001 · MH
DHEA EFFECTS ON MOOD IN DEPRESSED HIV+ PATIENTS$30,454
R01 · FY2001 · MH
DHEA EFFECTS ON MOOD IN DEPRESSED HIV+ PATIENTS$354,654
R01 · FY2000 · MH
MOOD EFFECT OF TESTOSTERONE VS FLUOXETINE IN HIV ILLNESS$258,740
R01 · FY2000 · MH